LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
Want to see LBRX full AI Analyst Report?
LB Pharmaceuticals, Inc. (LBRX) Ownership Overview
24.62% Insiders
13.02% Mutual Funds
9.05% Other Institutional Investors
7.34% ETFs
45.97% Public Companies and
Individual Investors
The ownership structure of LB Pharmaceuticals, Inc. (LBRX) stock is a mix of institutional, retail, and individual investors. Approximately 29.41% of the company’s stock is owned by Institutional Investors, 24.62% is owned by Insiders, and 45.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 16, 2025 | xxxxxxxxxxxxx | $4999995 | |
Sep 16, 2025 | xxxxxxxxxxxxx | $15000000 | |
Sep 16, 2025 | xxxxxxxxxxxxx | $15000000 | |
Sep 16, 2025 | xxxxxxxxxxxxx | $39999990 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,352,804 | Insider | 11.69% | 100,584,120 | |
| 2,208,604 | Institution | 7.70% | 66,258,120 | |
| 1,411,681 | Insider | 4.92% | 42,350,430 | |
| 1,411,681 | Insider | 4.92% | 42,350,430 | |
| 992,754 | Institution | 3.46% | 29,782,620 | |
| 883,677 | Insider | 3.08% | 26,510,310 | |
| 873,223 | Institution | 3.05% | 26,196,690 | |
| 761,013 | Institution | 2.65% | 22,830,390 | |
| 729,316 | Institution | 2.54% | 21,879,480 | |
| 567,627 | Institution | 1.98% | 17,028,810 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 873,223 | Institution | 3.05% | 26,196,690 | |
| 729,316 | Institution | 2.54% | 21,879,480 | |
| 567,627 | Institution | 1.98% | 17,028,810 | |
| 235,450 | Institution | 0.82% | 7,063,500 | |
| 231,150 | Institution | 0.81% | 6,934,500 | |
| 221,731 | Institution | 0.77% | 6,651,930 | |
| 208,114 | Institution | 0.73% | 6,243,420 | |
| 176,462 | Institution | 0.62% | 5,293,860 | |
| 113,056 | Institution | 0.39% | 3,391,680 | |
| 108,307 | Institution | 0.38% | 3,249,210 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 599,100 | Institution | 2.09% | 16,756,827 | |
| 449,084 | Institution | 1.57% | 13,472,520 | |
| 276,249 | Institution | 0.96% | 7,726,685 | |
| 115,675 | Institution | 0.40% | 3,476,034 | |
| 98,764 | Institution | 0.34% | 2,762,429 | |
| 95,801 | Institution | 0.33% | 2,878,820 | |
| 82,358 | Institution | 0.29% | 2,470,740 | |
| 81,339 | Institution | 0.28% | 2,440,170 | |
| 61,831 | Institution | 0.22% | 1,854,930 | |
| 49,505 | Institution | 0.17% | 1,485,150 |
FAQ
Who Owns LB Pharmaceuticals, Inc. (LBRX)?
According to the latest TipRanks data, approximately 9.05% of the company's stock is held by institutional investors, 24.62% is held by insiders, and 45.97% is held by retail investors.
What percentage of LB Pharmaceuticals, Inc. (LBRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.05% of LB Pharmaceuticals, Inc. (LBRX) stock is held by institutional investors.
What percentage of LB Pharmaceuticals, Inc. (LBRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.97% of LB Pharmaceuticals, Inc. (LBRX) stock is held by retail investors.
Who owns the most shares of LB Pharmaceuticals, Inc. (LBRX)?
Deep Track Biotechnology Master Fund, Ltd. owns the most shares of LB Pharmaceuticals, Inc. (LBRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.